Panbela Therapeutics, Inc.
PBLA
$0.2603
-$0.0607-18.91%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -0.55% | -0.28% | -9.98% | 17.40% | -34.26% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 160.39% | -627.01% | -27.89% | 231.03% | -136.80% |
| Change in Net Operating Assets | -32.81% | 385.64% | -175.19% | 145.33% | 539.73% |
| Cash from Operations | -116.11% | 89.55% | -204.94% | 53.87% | -16.30% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | -- | -- | -100.00% | -- |
| Cash from Investing | -100.00% | -- | -- | -100.00% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 88.69% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | 94.74% | -280.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | 102.81% | -3,758.33% | -- | 100.00% |
| Cash from Financing | -- | -100.00% | 49.13% | 25,094.74% | -100.25% |
| Foreign Exchange rate Adjustments | 0.00% | 150.00% | -400.00% | 200.00% | -166.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 140.89% | 91.23% | -238.60% | 126.53% | -419.70% |